Search
for

    Sort by

    Research 181–210 of 1000+

    1. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    2. No increased risk of CV events with dutasteride vs finasteride Reactions Weekly · 2016
    3. Comparison of Different Alpha-blocker Combinations in Male Hypertensives with Refractory Lower Urinary Tract Symptoms Korean Journal of Andrology · 2011 · 8 citations
    4. Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia Journal of pharmaceutical sciences · 2013 · 13 citations
    5. Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs Archivio italiano di urologia, andrologia · 2016
    6. The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model Asian Journal of Andrology · 2018 · 11 citations
    7. Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis The World Journal of Men's Health · 2019 · 4 citations
    8. The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review Consilium Medicum · 2025
    9. Caffeine’s Mechanisms of Action and Its Cosmetic Use Skin Pharmacology and Physiology · 2012 · 153 citations
    10. Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors Uro · 2021 · 6 citations
    11. African Journal of Biomedical Research 2025
    12. Finasteride para disminuir el sangrado en resección transuretral de próstata en pacientes con sonda Foley Revista del Hospital Juárez de México · 2014
    13. ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF 2024
    14. Finasterid in der Behandlung der benignen Prostatahyperplasie Der Urologe · 2012 · 1 citations
    15. Synthesis and Study of Some 17a-aza-D-homo Steroids as 5α-Reductase Inhibitors Current Drug Discovery Technologies · 2020 · 1 citations
    16. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology The BMJ · 2013 · 70 citations
    17. Uromedic® Pumpkin Seed Derived Δ7-Sterols, Extract and Oil Inhibit 5α-Reductases and Bind to Androgen Receptor <em>in Vitro</em> Pharmacology & pharmacy · 2018 · 12 citations
    18. Ejaculatory dysfunction in the treatment of lower urinary tract symptoms Translational Andrology and Urology · 2016 · 26 citations
    19. Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia Pharmaceutical biology · 2019 · 16 citations
    20. Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers Annals of Dermatology · 2011 · 3 citations
    21. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese Human Genomics · 2024 · 1 citations
    22. Catecholaminergic neurons boost fibroblast osteogenic activity in keloid Nature Communications · 2026
    23. An Integrated Approach to Develop Innovative, Sustainable, and Effective Cosmetic Ingredients: The Case Report of Fatty-Acids-Enriched Wild Strawberry Waste Extract Applied Sciences · 2024
    24. The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia International Journal of Molecular Sciences · 2024
    25. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    26. Floppy Iris Syndrome Essentials in ophthalmology · 2022
    27. Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review Journal of Clinical Medicine · 2021 · 34 citations
    28. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    29. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia Hormone Molecular Biology and Clinical Investigation · 2015 · 20 citations
    30. A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride BMC Musculoskeletal Disorders · 2018 · 4 citations